89bio Inc [ETNB] stock is trading at $8.70, up 2.72%. An important factor to consider is whether the stock is rising or falling in short-term value. The ETNB shares have gain 21.68% over the last week, with a monthly amount drifted -18.84%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
89bio Inc [NASDAQ: ETNB] stock has seen the most recent analyst activity on March 14, 2025, when Goldman initiated its Neutral rating and assigned the stock a price target of $11. Previously, Citigroup started tracking the stock with Buy rating on March 13, 2025, and set its price target to $25. On February 04, 2025, Wolfe Research initiated with a Outperform rating. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $15 on January 12, 2024. Oppenheimer downgraded its rating to Perform for this stock on October 10, 2023. In a note dated August 28, 2023, UBS initiated an Buy rating and provided a target price of $36 on this stock.
89bio Inc [ETNB] stock has fluctuated between $5.99 and $13.71 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $8.70 at the most recent close of the market. An investor can expect a potential return of 152.87% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -0.81 and Total Capital is -0.87. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.44 points at the first support level, and at 8.18 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.89, and for the 2nd resistance point, it is at 9.08.
Ratios To Look Out For
For context, 89bio Inc’s Current Ratio is 13.19. On the other hand, the Quick Ratio is 13.19, and the Cash Ratio is 3.49.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Jan 30 ’25 when 5.71 million shares were purchased. Director, McWherter Charles completed a deal on Jan 22 ’25 to buy 10000.0 shares. Meanwhile, Director McWherter Charles bought 5000.0 shares on Jan 21 ’25.
